PT-141, also known as Bremelanotide, became the first FDA-approved treatment specifically targeting hypoactive sexual desire disorder in women, validating decades of research into melanocortin-based sexual function modulation
DOI: 10.137/journal.pone.0058299 41
When pregnant rats were kept on a copper-deficient diet, the embryos displayed low SOD activity, increased super oxide anion radical level, and higher incidence of DNA damage and malformations [34]
Theyve shown remarkable efficacy in helping people lose significant amounts of weight in a short amount of time
Turner RC, Cull CA, Frighi V, Holman RR
A big fear is that because the drugs suppress appetite, stopping them may reignite hunger and lead to weight regain